Teva Pharmaceutical

Evolution step-up growth trajectory upward trajectory
Pharma

How biosimilar developers are embracing next phase of US market

Although the so-called biosimilar ‘void’ could pose challenges to upcoming biosimilar availability, the opportunity it presents is also immense.
Teva

Teva to lay off 250 at for-sale API unit: report

Jun 10, 2026 10:56am
Teva

Teva's innovative drugs helped carry strong Q1

Apr 29, 2026 2:27pm
law and order concept

In Lilly patent spat, appeals court revives $177M verdict to Teva

Apr 17, 2026 10:16am
Teva

Teva launches new online schizophrenia community project

Apr 15, 2026 9:45am
Law Legal System Justice Crime concept Mallet Gavel Hammer and Scales on tabl

GSK, Teva quietly settle Coreg 'skinny label' dispute

Feb 11, 2026 11:40am